Powder: -20°C for 3 years | In solvent: -80°C for 1 year
17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain. 17(S)-HDHA serves as a precursor to 17(S)-resolvins and has intrinsic biological activity, such as the inhibition of TNF-α-induced interleukin-1β expression in human glioma cells and inhibition of TNF-α-induced leukocyte trafficking to the mouse air pouch.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 μg | 35 days | $ 175.00 | |
50 μg | 35 days | $ 315.00 | |
100 μg | 35 days | $ 580.00 | |
250 μg | 35 days | $ 1,360.00 |
Description | 17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain. 17(S)-HDHA serves as a precursor to 17(S)-resolvins and has intrinsic biological activity, such as the inhibition of TNF-α-induced interleukin-1β expression in human glioma cells and inhibition of TNF-α-induced leukocyte trafficking to the mouse air pouch. |
Molecular Weight | 344.49 |
Formula | C22H32O3 |
CAS No. | 92693-03-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Miscible
Ethanol: Miscible
DMF: Miscible
PBS (pH 7.2): 0.8 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
17(S)-HDHA 92693-03-3 17(S)HDHA 17HDHA 17(S) HDHA inhibitor inhibit